Geron GERN Stock
3.62 USD
{{ price }}
3.434283%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
United States
Exchange
NasdaqGS
Market Cap
2.14B USD
LOW - HIGH [24H]
3.58
-
4.05 USD
VOLUME [24H]
2.08M USD
{{ volume }}
P/E Ratio
0
Earnings per share
-0.32 USD
Geron Price Chart
Geron GERN Financial and Trading Overview
| Geron stock price | 3.62 USD |
| Previous Close | 3.09 USD |
| Open | 3.12 USD |
| Bid | 0 USD x 2200 |
| Ask | 0 USD x 3100 |
| Day's Range | 2.99 - 3.15 USD |
| 52 Week Range | 1.2 - 3.84 USD |
| Volume | 11.39M USD |
| Avg. Volume | 6.54M USD |
| Market Cap | 1.54B USD |
| Beta (5Y Monthly) | 0.895774 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.32 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.83 USD |
GERN Valuation Measures
| Enterprise Value | 1.25B USD |
| Trailing P/E | N/A |
| Forward P/E | -9.774194 |
| PEG Ratio (5 yr expected) | -1.63 |
| Price/Sales (ttm) | 3120.575 |
| Price/Book (mrq) | 4.7269893 |
| Enterprise Value/Revenue | 2524.677 |
| Enterprise Value/EBITDA | -8.335 |
Trading Information
Geron Stock Price History
| Beta (5Y Monthly) | 0.895774 |
| 52-Week Change | 146.34% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 3.84 USD |
| 52 Week Low | 1.2 USD |
| 50-Day Moving Average | 2.82 USD |
| 200-Day Moving Average | 2.61 USD |
GERN Share Statistics
| Avg. Volume (3 month) | 6.54M USD |
| Avg. Daily Volume (10-Days) | 9.05M USD |
| Shares Outstanding | 508.77M |
| Float | 449.67M |
| Short Ratio | 5.04 |
| % Held by Insiders | 0.12% |
| % Held by Institutions | 44.85% |
| Shares Short | 28.96M |
| Short % of Float | 5.71% |
| Short % of Shares Outstanding | 5.69% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1058:1000 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -30357.69% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -30.075% |
| Return on Equity (ttm) | -70.79% |
Income Statement
| Revenue (ttm) | 494K USD |
| Revenue Per Share (ttm) | 0.001 USD |
| Quarterly Revenue Growth (yoy) | -82.89% |
| Gross Profit (ttm) | -93668000 USD |
| EBITDA | -149636992 USD |
| Net Income Avi to Common (ttm) | -149924992 USD |
| Diluted EPS (ttm) | -0.33 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 380.74M USD |
| Total Cash Per Share (mrq) | 0.75 USD |
| Total Debt (mrq) | 55.84M USD |
| Total Debt/Equity (mrq) | 17.13 USD |
| Current Ratio (mrq) | 8.814 |
| Book Value Per Share (mrq) | 0.641 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -139770000 USD |
| Levered Free Cash Flow (ttm) | -87059504 USD |
Profile of Geron
| Country | United States |
| State | CA |
| City | Foster City |
| Address | 919 East Hillsdale Boulevard |
| ZIP | 94404 |
| Phone | 650 473 7700 |
| Website | https://www.geron.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 107 |
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.
Q&A For Geron Stock
What is a current GERN stock price?
Geron GERN stock price today per share is 3.62 USD.
How to purchase Geron stock?
You can buy GERN shares on the NasdaqGS exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Geron?
The stock symbol or ticker of Geron is GERN.
Which industry does the Geron company belong to?
The Geron industry is Biotechnology.
How many shares does Geron have in circulation?
The max supply of Geron shares is 591.28M.
What is Geron Price to Earnings Ratio (PE Ratio)?
Geron PE Ratio is now.
What was Geron earnings per share over the trailing 12 months (TTM)?
Geron EPS is -0.32 USD over the trailing 12 months.
Which sector does the Geron company belong to?
The Geron sector is Healthcare.
Geron GERN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
| NASDAQ Global Select Market Com NQGS | 7876.03 USD — |
-1.61
|
— — | 7852.08 USD — | 7955.84 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
| NASDAQ Biotechnology Total Retu XNBI | 4501.69 USD — |
-2.14
|
— — | 4479.13 USD — | 4578.05 USD — | — - | — — |
| Nasdaq US 700 Small Cap Index NQUS700SC | 2060.1 USD — |
-1.99
|
— — | 2051.95 USD — | 2093.4 USD — | — - | — — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
- {{ link.label }} {{link}}